These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33915345)

  • 1. Empagliflozin induced euglycemic diabetic ketoacidosis in a patient undergoing coronary artery bypass graft despite discontinuation of the drug 48 hours prior to the surgery.
    Kuchay MS; Mishra SK; Mehta Y
    Diabetes Metab Syndr; 2021; 15(3):909-911. PubMed ID: 33915345
    [No Abstract]   [Full Text] [Related]  

  • 2. Empagliflozin-Associated Euglycemic Diabtetic Ketoacidosis.
    Soni P; Kumar V; Saradna A; Kupfer Y
    Am J Ther; 2018; 25(6):e740-e741. PubMed ID: 29746292
    [No Abstract]   [Full Text] [Related]  

  • 3. Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature.
    Hernandez-Quiles C; Ramirez-Duque N; Acosta-Delgado D
    Curr Diabetes Rev; 2019; 15(4):259-262. PubMed ID: 30047331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
    Kitahara C; Morita S; Kishimoto S; Matsuno S; Uraki S; Takeshima K; Furukawa Y; Inaba H; Iwakura H; Ariyasu H; Furuta H; Nishi M; Akamizu T
    J Diabetes Investig; 2021 Apr; 12(4):664-667. PubMed ID: 32686282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
    Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
    Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report].
    Yamamoto M; Ide N; Kitajima S; Obayashi M; Asada K; Matsushima S; Ito M
    Yakugaku Zasshi; 2019; 139(11):1479-1483. PubMed ID: 31685745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Euglycemic diabetic ketoacidosis in type 2 diabetes with sodium glucose cotransporter 2 inhibitors.
    Wang AY; Hou SK; Li SJ; Kao WF
    Am J Emerg Med; 2017 Feb; 35(2):379.e5-379.e6. PubMed ID: 27614369
    [No Abstract]   [Full Text] [Related]  

  • 8. Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic.
    Ozer O; Yorulmaz G
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):110-111. PubMed ID: 33115581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus.
    Bilgin S; Duman TT; Kurtkulagi O; Yilmaz F; Aktas G
    J Coll Physicians Surg Pak; 2022 Jul; 32(7):928-930. PubMed ID: 35795946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.
    Sampani E; Sarafidis P; Dimitriadis C; Kasimatis E; Daikidou D; Bantis K; Papanikolaou A; Papagianni A
    BMC Nephrol; 2020 Jul; 21(1):276. PubMed ID: 32669085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Euglisemic diabetic ketoacidotic coma caused by dapagliflozin.
    Karakaya Z; Topal FE; Topal F; Payza U; Akyol PY
    Am J Emerg Med; 2018 Nov; 36(11):2136.e1-2136.e2. PubMed ID: 30150107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapagliflozin-Associated Diabetic Ketoacidosis.
    Chakinala RC; Chang AP; Solanki S; Haq KF; Cho R
    Am J Ther; 2018; 25(6):e765-e766. PubMed ID: 29672334
    [No Abstract]   [Full Text] [Related]  

  • 13. Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes Mellitus Receiving Oral Therapy.
    Dull RB; Spangler ML; Knezevich EL; Lau BM
    J Pharm Pract; 2019 Apr; 32(2):240-243. PubMed ID: 29241389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors.
    Isaacs M; Tonks KT; Greenfield JR
    Intern Med J; 2017 Jun; 47(6):701-704. PubMed ID: 28580740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature.
    Paul N; Jonklaas J
    Diabetes Metab Syndr; 2021; 15(1):361-363. PubMed ID: 33517150
    [No Abstract]   [Full Text] [Related]  

  • 16. Sodium-Glucose Cotransporter-2 Inhibitor-associated Euglycemic Diabetic Ketoacidosis: Lessons From a Case Series of 4 Patients Undergoing Coronary Artery Bypass Grafting Surgery.
    Chaudhry A; Roels C; Lee J
    Can J Diabetes; 2022 Dec; 46(8):843-850. PubMed ID: 36068154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin Use: A Case Report.
    Brown F; McColl T
    J Emerg Med; 2018 Jan; 54(1):109-111. PubMed ID: 29157798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Euglycemic Diabetic Ketoacidosis After Cardiac Surgery in a Patient Treated With Empagliflozin for Type 2 Diabetes Mellitus.
    Wohlrab P; Kainz M; Schiferer A; Zapletal B; Tschernko E
    J Cardiothorac Vasc Anesth; 2022 Jul; 36(7):2066-2069. PubMed ID: 34465512
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acidosis without marked hyperglycemia : Euglycemic diabetic ketoacidosis associated with SGLT2-Inhibitors].
    Valek R; Von der Mark J
    Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):145-148. PubMed ID: 27221094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ketogenic diet as a trigger for diabetic euglycaemic ketoacidosis in a patient under treatment with iSGLT2].
    Nubiola A; Ternianov A; Remolins I
    Hipertens Riesgo Vasc; 2020; 37(1):39-41. PubMed ID: 31734176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.